ECSP034517A - NEW DERIVATIVES OF M-AMINO-PHENIL-IMINO-IMIDAZOLIDINE FOR THE TREATMENT OF URINE INCONTINENCE - Google Patents

NEW DERIVATIVES OF M-AMINO-PHENIL-IMINO-IMIDAZOLIDINE FOR THE TREATMENT OF URINE INCONTINENCE

Info

Publication number
ECSP034517A
ECSP034517A EC2003004517A ECSP034517A ECSP034517A EC SP034517 A ECSP034517 A EC SP034517A EC 2003004517 A EC2003004517 A EC 2003004517A EC SP034517 A ECSP034517 A EC SP034517A EC SP034517 A ECSP034517 A EC SP034517A
Authority
EC
Ecuador
Prior art keywords
amino
treatment
imidazolidine
phenil
imino
Prior art date
Application number
EC2003004517A
Other languages
Spanish (es)
Inventor
Franz Esser
Pascale Pouzet
Hisato Kitagawa
Ikunobu Muramatsu
Kenji Sakai
Original Assignee
Boehringer Ingelheim Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma
Publication of ECSP034517A publication Critical patent/ECSP034517A/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/41641,3-Diazoles
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D233/00Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44Nitrogen atoms not forming part of a nitro radical
    • C07D233/50Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/10Drugs for disorders of the urinary system of the bladder
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02PCLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00Technologies relating to chemical industry
    • Y02P20/50Improvements relating to the production of bulk chemicals
    • Y02P20/55Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a derivados de m-amino-fenilimino-imidazolidina con un nuevo patrón de sustituyentes en el anillo de fenilo, a su uso para la preparación de medicamentos, en especial para el tratamiento de incontinencia de orina y a procedimientos de preparación de los mismos.The present invention relates to m-amino-phenylimino-imidazolidine derivatives with a new pattern of substituents on the phenyl ring, their use for the preparation of medicaments, especially for the treatment of urinary incontinence and preparation procedures for the same.

EC2003004517A 2000-10-14 2003-03-17 NEW DERIVATIVES OF M-AMINO-PHENIL-IMINO-IMIDAZOLIDINE FOR THE TREATMENT OF URINE INCONTINENCE ECSP034517A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE10051005 2000-10-14

Publications (1)

Publication Number Publication Date
ECSP034517A true ECSP034517A (en) 2003-04-25

Family

ID=7659815

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2003004517A ECSP034517A (en) 2000-10-14 2003-03-17 NEW DERIVATIVES OF M-AMINO-PHENIL-IMINO-IMIDAZOLIDINE FOR THE TREATMENT OF URINE INCONTINENCE

Country Status (23)

Country Link
EP (1) EP1328517A2 (en)
JP (1) JP2004511547A (en)
KR (1) KR20030046503A (en)
CN (1) CN1471514A (en)
AR (1) AR035923A1 (en)
AU (1) AU2002215943A1 (en)
BG (1) BG107711A (en)
BR (1) BR0114603A (en)
CA (1) CA2425563A1 (en)
CZ (1) CZ20031333A3 (en)
DE (1) DE10150312A1 (en)
EA (1) EA200300460A1 (en)
EC (1) ECSP034517A (en)
EE (1) EE200300177A (en)
HU (1) HUP0302245A3 (en)
IL (1) IL155338A0 (en)
MX (1) MXPA03003162A (en)
NO (1) NO20031697L (en)
PL (1) PL361359A1 (en)
SK (1) SK4342003A3 (en)
WO (1) WO2002032876A2 (en)
YU (1) YU28203A (en)
ZA (1) ZA200302345B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4168086B1 (en) * 2008-04-16 2008-10-22 国立大学法人福井大学 Imidazoline derivatives

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2806811A1 (en) * 1978-02-17 1979-08-23 Boehringer Sohn Ingelheim NEW SUBSTITUTED 2-PHENYLIMINO-IMIDAZOLIDINE, THEIR ACID-ADDITIONAL SALTS, THESE MEDICINAL PRODUCTS AND METHOD FOR MANUFACTURING THE SAME
CA1201066A (en) * 1981-11-20 1986-02-25 Alcon Laboratories, Inc. N-¬3,5-dichloro-4-(2-imidazolidinylideneamino)- phenyl|-acetamide solutions for lowering intraocular pressure
DE19514579A1 (en) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Use of alpha-1-olone agonists for the treatment of urinary incontinence

Also Published As

Publication number Publication date
KR20030046503A (en) 2003-06-12
EP1328517A2 (en) 2003-07-23
IL155338A0 (en) 2003-11-23
AR035923A1 (en) 2004-07-28
SK4342003A3 (en) 2003-10-07
MXPA03003162A (en) 2004-12-06
AU2002215943A1 (en) 2002-04-29
YU28203A (en) 2006-05-25
BR0114603A (en) 2003-10-14
EE200300177A (en) 2003-08-15
WO2002032876A2 (en) 2002-04-25
CN1471514A (en) 2004-01-28
EA200300460A1 (en) 2004-02-26
HUP0302245A2 (en) 2003-10-28
PL361359A1 (en) 2004-10-04
CZ20031333A3 (en) 2003-08-13
NO20031697L (en) 2003-05-26
BG107711A (en) 2004-02-27
JP2004511547A (en) 2004-04-15
NO20031697D0 (en) 2003-04-11
DE10150312A1 (en) 2002-07-04
HUP0302245A3 (en) 2004-01-28
CA2425563A1 (en) 2002-04-25
ZA200302345B (en) 2004-04-23
WO2002032876A3 (en) 2002-07-18

Similar Documents

Publication Publication Date Title
DOP2002000433A (en) 2-TIO-3,5-DICIANO-4-FENIL-6-SUBSTITUTED AMINOPIRIDINS AND THEIR USE
UY27571A1 (en) 2-TIO-3, 5-DICIAN-4-PHENYL-6-REPLACED AMINOPIRIDINS AND THEIR USE
BRPI0408024A (en) antineoplastic combinations, comprising a rapamycin derivative and an aromatase inhibitor
PT1351958E (en) IMIDAZOLO-5-IL-2-ANILINE-PYRIMIDINES AS AGENTS FOR THE INHIBITION OF CELLULAR PROLIFERATION
ATE302775T1 (en) CARBOLINE DERIVATIVES
HN2000000267A (en) SUBSTITUTED OXAZOLIDINONES AND ITS USE
UY27604A1 (en) CHEMICAL COMPOUNDS.
ATE346067T1 (en) CARBOLINE DERIVATIVES
BR0107770A (en) 3-Phenoxy-1-phenyl acetylene derivatives and their use as herbicides
UY29213A1 (en) DERIVATIVES OF QUINOLIN AND ISOQUINOLINE 5-SUSTITIUED, A PROCEDURE FOR THEIR PREPARATION AND ITS USE AS INFLAMMATION INHIBITORS
AR040130A1 (en) ETONOGESTREL ESTERES, ITS USE AS ANTICOPCEPTIVE AND FOR THE TREATMENT OF GYNECOLOGICAL DISORDERS
UY28622A1 (en) QUINOLONA ANTIBACTERIAL AGENTS
ATE302776T1 (en) CONDENSED PYRIDOINDOLE DERIVATIVES
ATE259813T1 (en) TRIAZOLOPYRIMIDE DERIVATIVES
ATE330958T1 (en) PYRAZINO 1'2':1,6ÖPYRIDO 3,4-BÖINDOL DERIVATIVES
ECSP034517A (en) NEW DERIVATIVES OF M-AMINO-PHENIL-IMINO-IMIDAZOLIDINE FOR THE TREATMENT OF URINE INCONTINENCE
SV2006002220A (en) DERIVATIVES OF ALQUILIDEN-TETRAHIDRONAFTALENO, PROCEDURE FOR THEIR PREPARATION AND ITS USE AS ANTI-INFLAMMATORY REF. P-SV-78.836 / CD
HN2000000056A (en) NEW CRYSTAL FORMS OF AN ANTIBIOTIC MACROLID
UY26961A1 (en) NEW DERIVATIVES OF M-AMINO-PHENIL-IMINO-IMIDAZOLIDINE FOR THE TREATMENT OF URINE INCONTINENCE
CR8162A (en) PYRIDINYLANILIDES
ES2166026T3 (en) DERIVATIVES OF 1,2,3-BENZOTIADIAZOL AND ITS USE AS MICROBICIDES.
ECSP034632A (en) USE OF 6-DIMETILAMINOMETIL-1-FENIL-CICLOHEXACO SUBSTITUTED COMPOUNDS IN URINARY INCONTINENCE THERAPY
CO5550429A2 (en) LACTONE FORMULATIONS AND METHODS OF USE
ECSP034700A (en) NEW DERIVATIVES OF M-ALQUIL-FENILIMINO-IMIDAZOLIDANA TO TREAT URINARY INCONTINENCE
AR021616A1 (en) CYCLHEPTENOS SUBSTITUTED, PROCEDURE FOR THE PREPARATION AND USE OF THE SAME.